Meprotixol
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162630This classification denotes an antitussive agent with the molecular formula C19H23NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 2JXZ154Z0Q, chemically known as 9h-thioxanthen-9-ol, 9-(3-(dimethylamino)propyl)-2-methoxy- but more generally known as meprotixol, which bears US NIH Compound Identifier 71195. European Medicines Agency schedules Meprotixol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08759MIG. The term MEPROTIXOL is an International Non-Proprietary Name. World Health Organization schedules meprotixol in its Anatomical Therapeutic Chemical (ATC) Classification. MEPROTIXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule meprotixol under HS 29349990 and SITC 51579. As of Q4 2014, MEPROTIXOL remains US FDA's Preferred Term for this commodity. Meprotixol bears US NLM identifiers UMLS ID C2981321 and NCI Concept Code C87660. SMILES: S1C2C(C(O)(CCCN(C)C)C3C1CCCC3)CC(OC)CC2.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.